Recombinant multi-species KIF15 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine KIF15 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
Predicted to enable ATP hydrolysis activity; microtubule binding activity; and plus-end-directed microtubule motor activity. Predicted to be involved in centrosome separation; microtubule-based movement; and mitotic spindle assembly. Located in membrane. [provided by Alliance of Genome Resources, Feb 2025]
The Alternative Names of target: 3110023M17Rik,3930402I10Rik,BRDCS2,D330038N01,HKLP2,KIF15,KLP2,KNSL7,Kif15,Kinesin-like protein 2 (hKLP2),Kinesin-like protein 7,Kinesin-like protein KIF15,Knsl7,NY-BR-62,Serologically defined breast cancer antigen NY-BR-62,b2b1117.1Clo,b2b1117.1aClo

Target products collectionGo to KIF15 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP10495-Ag-1/ GM-Tg-hg-IP10495-Ag-2 Human KIF15 protein Human
GM-Tg-rg-IP10495-Ag-1/ GM-Tg-rg-IP10495-Ag-2 Rat KIF15 protein Rat
GM-Tg-mg-IP10495-Ag-1/ GM-Tg-mg-IP10495-Ag-2 Mouse KIF15 protein Mouse
GM-Tg-cynog-IP10495-Ag-1/ GM-Tg-cynog-IP10495-Ag-2 Cynomolgus/Rhesus macaque KIF15 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP10495-Ag-1/ GM-Tg-felg-IP10495-Ag-2 Feline KIF15 protein Feline
GM-Tg-cang-IP10495-Ag-1/ GM-Tg-cang-IP10495-Ag-2 Canine KIF15 protein Canine
GM-Tg-bovg-IP10495-Ag-1/ GM-Tg-bovg-IP10495-Ag-2 Bovine KIF15 protein Bovine
GM-Tg-equg-IP10495-Ag-1/ GM-Tg-equg-IP10495-Ag-2 Equine KIF15 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP10495-Ag-1/ GM-Tg-hg-IP10495-Ag-2; GM-Tg-rg-IP10495-Ag-1/ GM-Tg-rg-IP10495-Ag-2;
GM-Tg-mg-IP10495-Ag-1/ GM-Tg-mg-IP10495-Ag-2; GM-Tg-cynog-IP10495-Ag-1/ GM-Tg-cynog-IP10495-Ag-2;
GM-Tg-felg-IP10495-Ag-1/ GM-Tg-felg-IP10495-Ag-2; GM-Tg-cang-IP10495-Ag-1/ GM-Tg-cang-IP10495-Ag-2;
GM-Tg-bovg-IP10495-Ag-1/ GM-Tg-bovg-IP10495-Ag-2; GM-Tg-equg-IP10495-Ag-1/ GM-Tg-equg-IP10495-Ag-2
Products Name KIF15 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name KIF15
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine KIF15 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.